Cargando…
P1602: THE ASSESSMENT OF LYMPHOPENIA AS RISK FACTOR FOR UNFAVORABLE EVOLUTION OF PATIENTS WITH SEVERE FORM OF COVID 19
Autores principales: | Popov, V., Iliescu, L., Grigorie, A., Pirvu, C., Constantin, O., Badea, A., Badoiu Niculae, M. D., Rus, A., Calen, A., Bumbea, H., Mastalier, B., Andreescu, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430569/ http://dx.doi.org/10.1097/01.HS9.0000849264.66736.e0 |
Ejemplares similares
-
AML-168: The Assessment of COVID-19 Evolution in Patients with Oncological Diseases Admitted in an Intensive Care Unit of One Romanian Center
por: Popov, Viola Maria, et al.
Publicado: (2021) -
Poster: AML-168: The Assessment of COVID-19 Evolution in Patients with Oncological Diseases Admitted in an Intensive Care Unit of One Romanian Center
por: Popov, Viola Maria, et al.
Publicado: (2021) -
P1601: THE ASSESSMENT OF PREDICTIVE ROLE OF PROTEIN C AND S FOR CRITICAL FORM OF COVID-19
por: Popov, V., et al.
Publicado: (2022) -
Assessment of Hematologic and Coagulation Parameters As Predictive Value in COVID-19 with Unfavourable Evolution
por: Popov, Viola Maria, et al.
Publicado: (2020) -
CT-365: The Evaluation of Haematological and Biochemistry Parameters in COVID-19 Patients as a Predictive Factor for Unfavourable Evolution
por: Popov, Viola, et al.
Publicado: (2020)